These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33030793)

  • 1. Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method.
    Arai S; Kamijo T; Hayashi F; Shinohara S; Arai N; Sugano M; Uehara T; Honda T; Okumura N
    Int J Lab Hematol; 2021 Apr; 43(2):281-289. PubMed ID: 33030793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated screening procedure for the phenotypes of congenital fibrinogen disorders using novel parameters, |min1|c and Ac/|min1|c, obtained from clot waveform analysis using the Clauss method.
    Arai S; Kamijo T; Kaido T; Yoda M; Shinohara S; Suzuki T; Arai N; Sugano M; Uehara T; Okumura N
    Clin Chim Acta; 2021 Oct; 521():170-176. PubMed ID: 34273336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders.
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Arai N; Kikuchi R; Matsushita T
    Thromb Res; 2019 Feb; 174():98-103. PubMed ID: 30584960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia.
    Xiang L; Luo M; Yan J; Liao L; Zhou W; Deng X; Deng D; Cheng P; Lin F
    J Clin Lab Anal; 2018 May; 32(4):e22322. PubMed ID: 28922493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.
    Miesbach W; Schenk J; Alesci S; Lindhoff-Last E
    Thromb Res; 2010 Dec; 126(6):e428-33. PubMed ID: 20947138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Fibrinogen Determination Methods in Differential Diagnosis of Hypofibrinogenemia and Dysfibrinogenemia.
    Skornova I; Simurda T; Stasko J; Horvath D; Zolkova J; Holly P; Brunclikova M; Samos M; Bolek T; Schnierer M; Slavik L; Kubisz P
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital fibrinogen disorders with repeated thrombosis.
    Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X
    J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of comparing fibrinogen Clauss and prothrombin time derived method.
    Llamas P; Santos AB; Outeiriño J; Soto C; Tomás JF
    Thromb Res; 2004; 114(1):73-4. PubMed ID: 15262488
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis.
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Kurono H; Arai N; Okamoto S; Suzuki N; Tamura S; Kikuchi R; Katsumi A; Kojima T; Matsushita T
    Sci Rep; 2022 Jan; 12(1):434. PubMed ID: 35064141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Clauss and prothrombin time derived method ratio can differentiate dysfibrinogenemia from hypofibrinogenemia and hyperfibrinogenemia.
    Luo M; Xiang L; Yan J; Liao L; Wu Y; Deng X; Deng D; Cheng P; Lin F
    Thromb Res; 2020 Oct; 194():197-199. PubMed ID: 32788118
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the prothrombin time-derived and Clauss assays for the measurement of plasma fibrinogen in hospitalized dogs.
    Hasiuk MH; Russell KE; Jeffery U
    Vet Clin Pathol; 2020 Sep; 49(3):394-400. PubMed ID: 32654209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving equivalence in fibrinogen evaluation between the prothrombin time-derived fibrinogen assay and Clauss method using a pooled plasma calibrator.
    Wang S; Duan X; Liu X; Wu L; Zhang Y; Jin X
    J Clin Pathol; 2021 Jan; 74(1):58-63. PubMed ID: 32611762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of plasma fibrinogen concentrations in beagle dogs, cynomolgus monkeys, New Zealand white rabbits, and Sprague-Dawley rats by using Clauss and prothrombin-time-derived assays.
    Ameri M; Schnaars HA; Sibley JR; Honor DJ
    J Am Assoc Lab Anim Sci; 2011 Nov; 50(6):864-7. PubMed ID: 22330778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders.
    Mohsenian S; Seidizadeh O; Mirakhorli M; Jazebi M; Azarkeivan A
    Transfus Apher Sci; 2021 Dec; 60(6):103203. PubMed ID: 34275736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Selected ROTEM Parameters, Kinetics of Fibrinogen Polymerization and Plasmin Amidolytic Activity in Patients with Congenital Fibrinogen Defects.
    Treliński J; Pachniewska K; Matczak J; Robak M; Chojnowski K
    Adv Clin Exp Med; 2016; 25(6):1255-1263. PubMed ID: 28028981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
    Castaman G; Giacomelli SH; Biasoli C; Contino L; Radossi P
    Eur J Haematol; 2019 Oct; 103(4):379-384. PubMed ID: 31314131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen.
    Mackie J; Lawrie AS; Kitchen S; Gaffney PJ; Howarth D; Lowe GD; Martin J; Purdy G; Rigsby P; Rumley A
    Thromb Haemost; 2002 Jun; 87(6):997-1005. PubMed ID: 12083508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misdiagnosis of a patient with congenital dysfibrinogenemia: A case report and literature review.
    Chen X; Yan J; Xiang L; Lin F
    J Clin Lab Anal; 2022 Sep; 36(9):e24624. PubMed ID: 35949040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.